Skip to main content

Table 12 Prediction metrics for studies reporting sensitivity and specificity

From: Prediction of resistance to chemotherapy in ovarian cancer: a systematic review

Study

Prediction

Sensitivity

Specificity

LR+ve†

LR-ve†

P(C+)†

P(C−)†

P(C+|T+)†

P(C+|T−)†

Li et al. [3]

Chemoresistance

0.96*

0.23*

1.24

0.18

\(\frac {22}{44}\)

\(\frac {22}{44}\)

0.55

0.15

Obermayr et al. [27]

RFS

0.22*

0.85*

1.47

0.92

\(\frac {46}{216}\)

\(\frac {170}{216}\)

0.28

0.77

Ferriss et al. [33]

Chemoresponse

0.94*

0.29*

1.33

0.20

\(\frac {85}{119}\)

\(\frac {34}{119}\)

0.77

0.07

Sabatier et al. [37]

Prognosis

0.62*

0.62*

1.64

0.62

\(\frac {194}{366}\)

\(\frac {172}{366}\)

0.65

0.35

Yoshihara et al. [43]

PFS

0.64*

0.69*

2.06

0.52

\(\frac {45}{87}\)

\(\frac {39}{87}\)

0.69

0.30

Williams et al. [44]

Prognosis

0.77*

0.56*

1.75

0.41

\(\frac {97}{143}\)

\(\frac {46}{143}\)

0.79

0.16

Gevaert et al. [49]

Chemoresistance

0.67*

0.40*

1.12

0.82

\(\frac {15}{45}\)

\(\frac {30}{45}\)

0.36

0.62

Helleman et al. [53]

Chemoresistance

0.89*

0.56*

2.02

0.20

\(\frac {9}{72}\)

\(\frac {63}{72}\)

0.22

0.58

De Smet et al. [52]

Chemoresistance

0.71†

0.83†

4.29

0.34

\(\frac {6}{13}\)

\(\frac {7}{13}\)

0.79

0.29

Raspollini et al. [56]

Prognosis

0.79†

0.46†

1.45

0.47

\(\frac {28}{52}\)

\(\frac {24}{52}\)

0.63

0.29

Hartmann et al. [57]

Prognosis

0.86*

0.86*

6.14

0.16

\(\frac {21}{28}\)

\(\frac {7}{28}\)

0.95

0.05

Selvanayagam et al. [59]

Chemoresistance

1.00†

1.00†

∞

0.00

\(\frac {4}{8}\)

\(\frac {4}{8}\)

1.00

0.00

Kamazawa et al. [61]

Chemoresponse

1.00*

0.83†

6.00

0.00

\(\frac {21}{27}\)

\(\frac {5}{27}\)

0.95

0.00

  1. *Value stated in reference.
  2. †Value calculated.
  3. C: condition presence.
  4. T: test result.
  5. RFS: Relapse Free Survival.
  6. PFS: Progression Free Survival.